Kenneth Blum is widely designated as Father of Psychiatric Genetics because of the of the DRD2 gene and its correlation with various psychiatric disorders including the “Reward Deficiency Syndrome” (RDS) which term he has coined. He is also known as the “Father of Neuro- Nutrient Therapy” for his discovery of successful nutrient therapy for RDS. He holds numerous domestic and foreign patents and is co-founder and Chairman & CSO of LifeGen Inc. He is a former Full Professor in the Department of Pharmacology, University of Texas Health Science Center, San Antonio, Texas; Volunteer Professor in the Department of Psychiatry & McKnight Brain Institute, University of Florida College of Medicine, Gainesville, Florida and Adjunct Full Professor of Psychiatry at the University of Vermont College of Medicine, Burlington, Vermont. He currently serves as Neuroscience advisor for Dominion Diagnostics., LLC North Kingstown, Rhode island, Malibu Beach Recovery Center, Malibu Beach California, and is the Scientifi c Director of PATH Foundation NY, New York. He is an honorary Faculty of IIOAB, India. He has been recently appointed Chief Scientific Officer(CSO) of G&G Holistic Addiction Treatment Centers in North Miami Beach Florida. To his credit he has over 400 publications in peer reviewed journals, 14 books and has received many awards including a Lifetime Achievement Award from the National Institute of Holistic Addiction Studies.
neuropsychopharmacology,genetics,genetics of alcoholism, neuropsychiatry,pharmacogenetics
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
